COPAXONE (glatiramer acetate), a medication used in the treatment of ambulatory patients with relapsing remitting multiple sclerosis (RRMS), can cause anaphylactic reactions, which may be fatal and can occur at any time during treatment, from as early as after the first dose or even months, up to years, after initiation of treatment.
RecallTracker